M&A / Deals Sun Pharma to acquire Innovcare Lifesciences for $28.7m Pharmaceutical TechnologySun Pharmaceutical Industries has agreed to purchase India-based Innovcare Lifesciences in a deal valued at approximately Rs2.71bn ($28.7m).Read full story pharminent June 22, 2026 (Last updated: June 22, 2026) Pharmaceutical Technology Sun Pharmaceutical Industries has agreed to purchase India-based Innovcare Lifesciences in a deal valued at approximately Rs2.71bn ($28.7m). Read full story Post navigation Previous: The first 14 days: How specialty programs set patients up for successNext: Post-marketing oncology studies: Enabling faster recruitment and lower costs Related Stories M&A / Deals Solstice Oncology secures $225m to drive porustobart’s development for cancer pharminent September 10, 2026 M&A / Deals UK’s Claret Capital raises 575m for European biotechs pharminent September 7, 2026 M&A / Deals GSK wagers up to $1.3B on a different kind of cancer drug pharminent September 3, 2026